FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808511206> ?p ?o ?g. }

• W2808511206 endingPage "672.e2" @default.
• W2808511206 startingPage "664" @default.
• W2808511206 abstract "Treatment outcomes have improved in lymphoid malignancies but relapse remains inevitable for most patients. Everolimus and lenalidomide have shown clinical activity as single agents in patients with relapsed and refractory Hodgkin and non-Hodgkin lymphomas.The present phase I/II trial for patients with relapsed and refractory lymphoid malignancy opened at Mayo Clinic from January 2011 to May 2013. The trial used a standard cohort 3 + 3 design to determine the maximum tolerated dose for the combination. Stem cell transplantation had failed in 27 of the patients (49%), 63% had stage IV disease, and ≥ 3 previous therapies had failed in 78%.Of the 58 patients, enrolled, 55 were evaluable for analysis. The maximum tolerated dose was 5 mg/d for everolimus plus 10 mg/d for 21 days for lenalidomide. The most common grade ≥ 3 toxicities were hematologic and included neutropenia (56%), leukopenia (38%), and thrombocytopenia (33%). Seven patients discontinued the study because of adverse events. One patient died of disease progression. The overall response rate was 27% (15 of 55), with 38% (21 of 55) having stable disease.The present phase I/II trial of everolimus and lenalidomide for R/R lymphoma has shown the combination to be tolerable, with neutropenia as the main dose-limiting toxicity. Encouraging responses were seen in this heavily pretreated group, and the patients with a response had meaningful duration of response." @default.
• W2808511206 created "2018-06-21" @default.
• W2808511206 creator A5000432344 @default.
• W2808511206 creator A5004152557 @default.
• W2808511206 creator A5025688165 @default.
• W2808511206 creator A5027394636 @default.
• W2808511206 creator A5037953446 @default.
• W2808511206 creator A5038693643 @default.
• W2808511206 creator A5041282679 @default.
• W2808511206 creator A5048737518 @default.
• W2808511206 creator A5058598134 @default.
• W2808511206 creator A5059729547 @default.
• W2808511206 creator A5061713890 @default.
• W2808511206 creator A5064206924 @default.
• W2808511206 creator A5064576471 @default.
• W2808511206 creator A5076892547 @default.
• W2808511206 creator A5087950597 @default.
• W2808511206 creator A5090009905 @default.
• W2808511206 date "2018-10-01" @default.
• W2808511206 modified "2023-10-18" @default.
• W2808511206 title "A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma" @default.
• W2808511206 cites W2003428294 @default.
• W2808511206 cites W2013811004 @default.
• W2808511206 cites W2017144533 @default.
• W2808511206 cites W2019874087 @default.
• W2808511206 cites W2047257824 @default.
• W2808511206 cites W2078761761 @default.
• W2808511206 cites W2092347914 @default.
• W2808511206 cites W2095669071 @default.
• W2808511206 cites W2096764404 @default.
• W2808511206 cites W2109429943 @default.
• W2808511206 cites W2116194748 @default.
• W2808511206 cites W2116572046 @default.
• W2808511206 cites W2128783106 @default.
• W2808511206 cites W2135860817 @default.
• W2808511206 cites W2136242714 @default.
• W2808511206 cites W2139836848 @default.
• W2808511206 cites W2145785161 @default.
• W2808511206 cites W2153493705 @default.
• W2808511206 cites W2153558008 @default.
• W2808511206 cites W2156522119 @default.
• W2808511206 cites W2163579973 @default.
• W2808511206 cites W2163790170 @default.
• W2808511206 cites W2169064989 @default.
• W2808511206 cites W2171239337 @default.
• W2808511206 cites W2266381519 @default.
• W2808511206 cites W2287519522 @default.
• W2808511206 cites W2414395973 @default.
• W2808511206 cites W2528264979 @default.
• W2808511206 cites W2580896801 @default.
• W2808511206 cites W2588544166 @default.
• W2808511206 cites W2605009867 @default.
• W2808511206 cites W2613329464 @default.
• W2808511206 cites W2744261860 @default.
• W2808511206 cites W2805784452 @default.
• W2808511206 cites W2979692070 @default.
• W2808511206 doi "https://doi.org/10.1016/j.clml.2018.06.013" @default.
• W2808511206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30104176" @default.
• W2808511206 hasPublicationYear "2018" @default.
• W2808511206 type Work @default.
• W2808511206 sameAs 2808511206 @default.
• W2808511206 citedByCount "6" @default.
• W2808511206 countsByYear W28085112062020 @default.
• W2808511206 countsByYear W28085112062021 @default.
• W2808511206 countsByYear W28085112062022 @default.
• W2808511206 countsByYear W28085112062023 @default.
• W2808511206 crossrefType "journal-article" @default.
• W2808511206 hasAuthorship W2808511206A5000432344 @default.
• W2808511206 hasAuthorship W2808511206A5004152557 @default.
• W2808511206 hasAuthorship W2808511206A5025688165 @default.
• W2808511206 hasAuthorship W2808511206A5027394636 @default.
• W2808511206 hasAuthorship W2808511206A5037953446 @default.
• W2808511206 hasAuthorship W2808511206A5038693643 @default.
• W2808511206 hasAuthorship W2808511206A5041282679 @default.
• W2808511206 hasAuthorship W2808511206A5048737518 @default.
• W2808511206 hasAuthorship W2808511206A5058598134 @default.
• W2808511206 hasAuthorship W2808511206A5059729547 @default.
• W2808511206 hasAuthorship W2808511206A5061713890 @default.
• W2808511206 hasAuthorship W2808511206A5064206924 @default.
• W2808511206 hasAuthorship W2808511206A5064576471 @default.
• W2808511206 hasAuthorship W2808511206A5076892547 @default.
• W2808511206 hasAuthorship W2808511206A5087950597 @default.
• W2808511206 hasAuthorship W2808511206A5090009905 @default.
• W2808511206 hasConcept C121332964 @default.
• W2808511206 hasConcept C126322002 @default.
• W2808511206 hasConcept C141071460 @default.
• W2808511206 hasConcept C142424586 @default.
• W2808511206 hasConcept C143998085 @default.
• W2808511206 hasConcept C197934379 @default.
• W2808511206 hasConcept C2776063141 @default.
• W2808511206 hasConcept C2776364478 @default.
• W2808511206 hasConcept C2777063308 @default.
• W2808511206 hasConcept C2778375690 @default.
• W2808511206 hasConcept C2778850193 @default.
• W2808511206 hasConcept C2779338263 @default.
• W2808511206 hasConcept C2779699572 @default.
• W2808511206 hasConcept C2780873365 @default.
• W2808511206 hasConcept C29730261 @default.

• next